Effects of chemical chaperones on partially retarded NaCl cotransporter mutants associated with Gitelman's syndrome in a mouse cortical collecting duct cell line
Author(s) -
J.C. de Jong,
Peter H.G.M. Willems,
Michel Goossens,
Alain Vandewalle,
Lambertus P. van den Heuvel,
Nine V.A.M. Knoers,
René J.M. Bindels
Publication year - 2004
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfg474
Subject(s) - chemical chaperone , gitelman syndrome , phenylbutyrate , distal convoluted tubule , mutant , cotransporter , reabsorption , symporter , endocrinology , medicine , microbiology and biotechnology , biochemistry , biology , chemistry , kidney , transporter , gene , hypomagnesemia , organic chemistry , magnesium , sodium
Epithelial cells lining the distal convoluted tubule express the thiazide-sensitive Na-Cl cotransporter (NCC) that is responsible for the reabsorption of 5-10% of the filtered load of Na(+) and Cl(-). Mutations in NCC cause the autosomal recessive renal disorder Gitelman's syndrome (GS). GS mutations give rise to mutant transporters that are either fully (class I) or partially (class II) retarded. Recent evidence indicates that class II mutations do not alter the intrinsic transport activity of NCC. These findings suggest that in GS caused by class II NCC mutations, pharmacological chaperones may be useful in treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom